CSIMarket Company Name, Ticker, Industry, else..
 
Transcode Therapeutics Inc   (NASDAQ: RNAZ)
Other Ticker:  
 
 

Transcode Therapeutics Inc Growth Comparisons

Select each growth Category to receive further Information




 
RNAZ Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q4 MRQ) - 11.85 % 6.56 % 5.68 %
Q / Q Revenue Growth (Q4 MRQ) - 2.77 % 2.01 % 2.64 %
Y / Y Revenue Growth (for 12 months ending Q4 TTM) - 6.32 % 5.04 % %
Sequential Revenue Growth (for 12 months ending Q4 TTM) - 2.17 % 1.28 % 1.73 %
Revenue 5 Year Average Growth - 8.98 % 8.2 % 7.6 %


RNAZ's Growth Comparisons in IV. Quarter 2024




Transcode Therapeutics Inc reported top-line of $ 0 millions in the fourth quarter 2024, compare to $ 0 millions in the same quarter a year ago. Revenues in the Major Pharmaceutical Preparations industry grew by 11.85%, while the top-line in the Healthcare sector increased by 6.56%, and overall market improved by 5.68% from the fourth quarter 2023.

Sequentially company's Revenue were unchanged from the third quarter results. . Looking into annual growth, sales grew by % on average in last five years, while S & P 500's including only Businesses with the fourth quarter 2024 earnings reports, average yearly sales growth is 7.6%.

RNAZ Growth Rates by Company's Segments

Segment Name
Y / Y
Sequential


Growth Rates of RNAZ's Income in the fourth quarter 2024


RNAZ Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q4 MRQ) - 145.88 % 37.16 % -0.25 %
Sequential Operating Income Change (Q4 MRQ) - -38.36 % -23.6 % -8.72 %
Y / Y Operating Income Growth (Q4 TTM) - 18.23 % 20.71 % 9.22 %
Sequential Operating Income Growth (Q4 TTM) - 14.05 % 7.01 % -0.24 %
Operating Income 5 Year Avg. Change - -1.96 % -1.88 % 9.14 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q4 MRQ) - 97.5 % 28.01 % 22.95 %
Sequential Income from Cont. Ops. Change (Q4 MRQ) - 14.65 % -14.66 % 8.12 %
Y / Y Income from Cont. Ops. Change (Q4 TTM) - 21.34 % 25.7 % 11.53 %
Sequential Income from Cont. Ops. Change (Q4 TTM) - 6.37 % -0.85 % 4.54 %
Income from Cont. Ops. 5 Year Avg. Change - -3.93 % -9.14 % 9.1 %

RNAZ Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q4 MRQ) - 101.83 % 29.83 % 25.79 %
Q / Q Net Income Growth (Q4 MRQ) - 16.72 % -20.3 % 7.59 %
Y / Y Net Income Change (Q4 TTM) - -22.71 % -7.71 % 9.64 %
Sequential Net Income Change (Q4 TTM) - 7.24 % -1.1 % 5.13 %
Net Income 5 Year Avg. Growth - -4.92 % -8.62 % 8.66 %

RNAZ's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q4 MRQ) - 92.27 % 28.01 % 22.95 %
Sequential EPS from Cont. Ops. Change (Q4 MRQ) - 16.49 % -14.66 % 8.12 %
Y / Y EPS from Cont. Ops. Change (Q4 TTM) - - - -
Sequential EPS from Cont. Ops. Change (Q4 TTM) - - - 33 %
EPS from Cont. Ops. 5 Year Avg. Growth - -12.56 % -9.14 % 9.1 %



RNAZ EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q4 MRQ) - 96.48 % 29.83 % 9.1 %
Q / Q EPS Net Growth (Q4 MRQ) - 18.6 % -20.3 % 7.59 %
Y / Y EPS Net Change (for 12 months ending Q4 TTM) - - - 92.65 %
Sequential EPS Net Change (for 12 months ending Q4 TTM) - - - 33 %
EPS Net 5 Year Avg. Change - -4.92 % -8.62 % 8.66 %



Transcode Therapeutics Inc reported bottom-line of $ -5.65 in the fourth quarter, compare to $ -552.61 in the same quarter a year ago. Major Pharmaceutical Preparations industry grew by 96.48%, while Healthcare sector increased by 29.83%, and overall market improved by 25.79%.

Sequentially company's EPS were unchanged from the third quarter results. . Looking into annual growth, income per share grew by % on average in the last five years, while the S & P 500's including only the businesses with the fourth quarter 2024 financial results, average yearly income per share growth is 8.66%.

RNAZ Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q4 MRQ) - 32.12 % 33.69 % 32.78 %
Sequential Free Cash Flow Change (Q4 MRQ) - -17.82 % -1.87 % 112.49 %
Y / Y Free Cash Flow Change (Q4 TTM) - 12.79 % 13.46 % 10.16 %
Sequential Free Cash Flow Change (Q4 TTM) 113.31 % 7.19 % 7.9 % 9.32 %
Free Cash Flow 5 Year Avg. Change - 8.77 % 4.67 % 8.29 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q4 MRQ) - -73.26 % - -81.06 %
Sequential Net Cash Flow Change (Q4 MRQ) - - - -
Y / Y Net Cash Flow Change (Q4 TTM) - - - -
Sequential Net Cash Flow Change (Q4 TTM) - - - -
Net Cash Flow 5 Year Avg. Change - -31.55 % -19.58 % 0.54 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q4 MRQ) - 3.64 % 6.92 % 22.3 %
Sequential Capital Expenditures Change (Q4 MRQ) -96.11 % 26.4 % 21.24 % 17.09 %
Y / Y Capital Expenditures Change (Q4 TTM) -49.66 % 3.88 % 3.56 % 41.38 %
Sequential Capital Expenditures Change (Q4 TTM) 2.87 % 1.03 % 1.51 % 6.81 %
Capital Expenditures 5 Year Avg. Change - 9.47 % 8.01 % 7.66 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com